Fulgent Genetics Total Current Assets 2015-2024 | FLGT

Fulgent Genetics total current assets from 2015 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
Fulgent Genetics Annual Total Current Assets
(Millions of US $)
2023 $508
2022 $628
2021 $612
2020 $524
2019 $37
2018 $40
2017 $33
2016 $26
2015 $3
2014 $1
Fulgent Genetics Quarterly Total Current Assets
(Millions of US $)
2024-06-30 $399
2024-03-31 $387
2023-12-31 $508
2023-09-30 $550
2023-06-30 $528
2023-03-31 $581
2022-12-31 $628
2022-09-30 $697
2022-06-30 $675
2022-03-31 $765
2021-12-31 $612
2021-09-30 $623
2021-06-30 $567
2021-03-31 $659
2020-12-31 $524
2020-09-30 $196
2020-06-30 $41
2020-03-31 $37
2019-12-31 $37
2019-09-30 $39
2019-06-30 $35
2019-03-31 $36
2018-12-31 $40
2018-09-30 $41
2018-06-30 $38
2018-03-31 $36
2017-12-31 $33
2017-09-30 $32
2017-06-30 $35
2017-03-31 $33
2016-12-31 $26
2016-09-30 $17
2016-06-30 $22
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2014-12-31 $1
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.613B $0.289B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $11.978B 0.00
Inspire Medical Systems (INSP) United States $6.055B 188.82
Hims & Hers Health (HIMS) United States $5.988B 154.89
Axonics (AXNX) United States $3.602B 1762.00
IRhythm Technologies (IRTC) United States $2.783B 0.00
Privia Health (PRVA) United States $2.736B 228.00
Enovis (ENOV) United States $2.646B 17.94
Omnicell (OMCL) United States $2.263B 74.03
Azenta (AZTA) United States $2.242B 127.33
10x Genomics (TXG) United States $1.925B 0.00
Clover Health Investments (CLOV) United States $1.657B 0.00
Schrodinger (SDGR) United States $1.422B 0.00
Phreesia (PHR) United States $1.252B 0.00
Standard BioTools (LAB) United States $0.830B 0.00
Talkspace (TALK) United States $0.586B 0.00
Butterfly Network (BFLY) United States $0.582B 0.00
Definitive Healthcare (DH) United States $0.508B 88.00
Health Catalyst (HCAT) United States $0.506B 0.00
Pulmonx (LUNG) United States $0.298B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.248B 0.00
TruBridge (TBRG) United States $0.214B 62.22
P3 Health Partners (PIII) United States $0.142B 0.00
American Well (AMWL) United States $0.139B 0.00
EUDA Health Holdings (EUDA) Singapore $0.106B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.064B 0.00
111 (YI) China $0.057B 0.00
Zepp Health (ZEPP) China $0.050B 0.00
Outset Medical (OM) United States $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
CareCloud (CCLD) United States $0.042B 0.00
Movano (MOVE) United States $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
MSP Recovery (LIFW) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00